Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase
- PMID: 6321134
- DOI: 10.1210/endo-114-3-1005
Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase
Abstract
TSH is known to interact on thyroid membranes with two classes of binding sites that differ in affinity and capacity. To assess the relevance of the class of TSH-binding sites characterized by low affinity and high capacity to the stimulation of adenylate cyclase, we studied the interactions of desialylated hCG (as-hCG) and its beta-subunit (as-hCG beta) with human thyroid membranes. In low ionic strength buffer, pH 7.8, where both classes of sites are operant, as-hCG fully inhibited and as-hCG beta partially inhibited [125I] bovine (b) TSH binding. Scatchard analysis of the [125I]bTSH binding inhibition curve in the presence of 1.0 X 10(-5) M as-hCG beta clearly indicated that as-hCG beta interacted only with the low affinity class of binding sites, leaving the high affinity class unaffected. In the presence of 140 mM NaCl, [125I]bTSH interacted predominantly with the high affinity class of binding sites; as-hCG fully inhibited [125I]bTSH binding to this class of sites, whereas as-hCG beta displayed essentially no interaction. Scatchard analysis of [125I]as-hCG beta binding to human thyroid membranes in low ionic strength buffer revealed a single apparent class of sites with low affinity (Kd = approximately 1.0 X 10(-6) M) and high capacity (Q = approximately 300 pmol/mg membrane protein). The bTSH preparation (Thytropar) showed a 10-fold greater binding inhibition potency at these sites than either the as-hCG or the as-hCG beta preparation, in keeping with the inference that as-hCG beta interacts with the low affinity class of TSH-binding sites. At a concentration more than 3 times that necessary to inhibit TSH binding to the low affinity class of sites, the as-hCG beta molecule neither stimulated adenylate cyclase nor inhibited the ability of TSH to do so. In contrast, the as-hCG molecule, which interacts with both classes of TSH-binding sites, fully inhibited TSH stimulation of adenylate cyclase. We conclude that the low affinity class of TSH-binding sites is not the class of sites through which TSH stimulates adenylate cyclase, and that this role is best ascribed to the high affinity class of TSH-binding sites.
Similar articles
-
Evidence that partially desialylated variants of human chorionic gonadotropin (hCG) are the factors in crude hCG that inhibit the response to thyrotropin in human thyroid membranes.Endocrinology. 1988 Sep;123(3):1535-43. doi: 10.1210/endo-123-3-1535. Endocrinology. 1988. PMID: 3402396
-
Design of a long-lived thyrotropin antagonist from derivatives of human chorionic gonadotropin.Endocrinology. 1989 Jan;124(1):223-32. doi: 10.1210/endo-124-1-223. Endocrinology. 1989. PMID: 2462487
-
Binding of bovine thyrotropin to receptors in rat testis and its interaction with gonadotropins.Endocrinology. 1978 Jul;103(1):101-11. doi: 10.1210/endo-103-1-101. Endocrinology. 1978. PMID: 217636
-
Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.J Clin Endocrinol Metab. 1983 Jul;57(1):140-7. doi: 10.1210/jcem-57-1-140. J Clin Endocrinol Metab. 1983. PMID: 6304132
-
Thyrotropic action of human chorionic gonadotropin.Thyroid. 1995 Oct;5(5):425-34. doi: 10.1089/thy.1995.5.425. Thyroid. 1995. PMID: 8563483 Review.
Cited by
-
Activities of deglycosylated thyrotropin at the thyroid membrane receptor-adenylate cyclase system.J Endocrinol Invest. 1985 Dec;8(6):537-41. doi: 10.1007/BF03348556. J Endocrinol Invest. 1985. PMID: 3009595
-
Novel insights on thyroid-stimulating hormone receptor signal transduction.Endocr Rev. 2013 Oct;34(5):691-724. doi: 10.1210/er.2012-1072. Epub 2013 May 3. Endocr Rev. 2013. PMID: 23645907 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources